West Nile virus

NEW YORK, July 28 (Praxis Press) In late August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York City and in neighboring counties. As a result, in May 2000, the Centers for Disease Control and Prevention (CDC) issued guidelines and provided funds to support mosquito-control and risk-reduction campaigns and surveillance in 19 states where WNV transmission had occurred or would likely occur. A new report by the CDC states that from May 6 through July 8, 20


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 28 (Praxis Press) In late August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York City and in neighboring counties. As a result, in May 2000, the Centers for Disease Control and Prevention (CDC) issued guidelines and provided funds to support mosquito-control and risk-reduction campaigns and surveillance in 19 states where WNV transmission had occurred or would likely occur. A new report by the CDC states that from May 6 through July 8, 2000, WNV infections were found in 26 birds from five counties in New York and New Jersey, but no cases of human or equine infection were reported in the region or in surrounding states. The CDC recommends that those areas where local transmission of WNV may have occurred should continue surveillance, mosquito larval control, and public education and outreach. Counties where WNV transmission occurred in 1999, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio